FTIDC (i.p. or p.o.; 1-30 mg/kg) reduces the duration of face-washing behavior elicited in a dosedependent manner and the inhibitory effect is statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o.[1].
| Animal Model: | Male CD1 (ICR) mice of 6-weeks-old[1] |
| Dosage: | 1, 3, 10, and 30 mg/kg |
| Administration: | I.p. or p.o. |
| Result: | Reduced the duration of face-washing behavior elicited in a dosedependent manner and was statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o..
|
